0001214659-20-000769.txt : 20200131 0001214659-20-000769.hdr.sgml : 20200131 20200131200328 ACCESSION NUMBER: 0001214659-20-000769 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200129 FILED AS OF DATE: 20200131 DATE AS OF CHANGE: 20200131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHEN ISAN CENTRAL INDEX KEY: 0001586218 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 20566630 MAIL ADDRESS: STREET 1: C/O MIRATI THERAPEUTICS, INC. STREET 2: 9393 TOWNE CENTRE DRIVE, STE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 marketforms-47609.xml PRIMARY DOCUMENT X0306 4 2020-01-29 0001576263 Mirati Therapeutics, Inc. MRTX 0001586218 CHEN ISAN C/O MIRATI THERAPEUTICS, INC. 9393 TOWNE CENTRE DRIVE, STE 200 SAN DIEGO CA 92121 false true false false EVP, Chief Medical Officer Common Stock 2020-01-29 4 M false 3002 24.99 A 39401 D Stock Options 24.99 2020-01-29 4 M false 3002 0 D 2026-01-21 Common Stock 3002 56754 D 1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested. Includes 392 shares acquired under the ESPP Purchase on 05/31/2019 and 171 shares acquired under the ESPP purchase on 11/29/2019. /s/ Vickie Reed, Attorney-in-Fact 2020-01-31